{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:46:09Z","timestamp":1776476769205,"version":"3.51.2"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.diabres.2018.04.015","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T05:52:00Z","timestamp":1524117120000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Pharmacotherapy for hyperglycemia in pregnancy \u2013 Do oral agents have a place?"],"prefix":"10.1016","volume":"145","author":[{"given":"Rosa","family":"Corcoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Balsells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apolonia","family":"Garc\u00eda-Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Shmueli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eran","family":"Hadar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2018.04.015_b0005","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa042973","article-title":"Effect of treatment of gestational diabetes mellitus on pregnancy outcomes","volume":"352","author":"Crowther","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2018.04.015_b0010","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2018.04.015_b0015","doi-asserted-by":"crossref","DOI":"10.2337\/diacare.26.4.1199","article-title":"Diabetes and abnormal glucose tolerance in women with previous gestational diabetes","volume":"26","author":"Albareda","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0020","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2337\/diabetes.49.12.2208","article-title":"Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships","volume":"49","author":"Dabelea","year":"2000","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2018.04.015_b0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2337\/diab.40.2.S121","article-title":"Long-term prospective evaluation of offspring of diabetic mothers","volume":"40","author":"Silverman","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2018.04.015_b0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2337\/diacare.10.1.76","article-title":"Obesity in offspring of diabetic Pima Indian women despite normal birth weight","volume":"10","author":"Pettitt","year":"1987","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0035","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/dme.12286","article-title":"Gestational diabetes predicts the risk of childhood overweight and abdominal circumference independent of maternal obesity","volume":"30","author":"Nehring","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2018.04.015_b0040","first-page":"219","article-title":"Is gestational diabetes an acquired condition?","volume":"1","author":"Aerts","year":"1979","journal-title":"J Dev Physiol"},{"key":"10.1016\/j.diabres.2018.04.015_b0045","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(03)13505-2","article-title":"Effect of a diabetic environment in utero on predisposition to type 2 diabetes","volume":"361","author":"Sobngwi","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2018.04.015_b0050","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2337\/diacare.25.12.2287","article-title":"Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers","volume":"25","author":"Stride","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0055","doi-asserted-by":"crossref","first-page":"e000221","DOI":"10.1136\/bmjdrc-2016-000221","article-title":"Trends in diabetes in pregnancy in Sweden 1998\u20132012","volume":"4","author":"Fadl","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0060","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJM200010193431608","article-title":"Oral hypoglycemic drugs for gestational diabetes","volume":"343","author":"Greene","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2018.04.015_b0065","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2018.04.015_b0070","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9378(91)90421-M","article-title":"Insignificant transfer of glyburide occurs across the human placenta","volume":"165","author":"Elliott","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.diabres.2018.04.015_b0075","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/AOG.0000000000000285","article-title":"Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000\u20132011","volume":"123","author":"Camelo Castillo","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.diabres.2018.04.015_b0080","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1464-5491.2011.03361.x","article-title":"Metformin for gestational diabetes in routine clinical practice","volume":"28","author":"Goh","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2018.04.015_b0085","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus Insulin for the Treatment of Gestational Diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2018.04.015_b0090","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/jog.12384","article-title":"Use of antidiabetic agents in the treatment of gestational diabetes mellitus in Germany, 2008\u20132012","volume":"40","author":"Heilmaier","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.diabres.2018.04.015_b0095","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.2337\/dc07-1620","article-title":"Counterpoint: oral hypoglyemic agents should be used to treat diabetic pregnant women","volume":"30","author":"Coetzee","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h102","article-title":"Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis","volume":"350","author":"Balsells","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2018.04.015_b0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jamapediatrics.2015.74","article-title":"Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes","volume":"169","author":"Camelo Castillo","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.diabres.2018.04.015_b0110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/clpt.2009.5","article-title":"Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice","volume":"85","author":"Hebert","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.diabres.2018.04.015_b0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.placenta.2017.05.016","article-title":"Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight","volume":"57","author":"D\u00edaz","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.diabres.2018.04.015_b0120","doi-asserted-by":"crossref","first-page":"e7939","DOI":"10.1097\/MD.0000000000007939","article-title":"Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: an updated PRISMA-compliant network meta-analysis","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.diabres.2018.04.015_b0125","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/aogs.12015","article-title":"On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome \u2013 an epi-analysis","volume":"91","author":"Vanky","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.diabres.2018.04.015_b0130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1515\/JPM.2005.092","article-title":"Perinatal outcomes and the use of oral hypoglycemic agents","volume":"33","author":"Bertini","year":"2005","journal-title":"J Perinat Med"},{"key":"10.1016\/j.diabres.2018.04.015_b0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/ajo.12276","article-title":"Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide \u2013 a randomised controlled trial","volume":"55","author":"George","year":"2015","journal-title":"Aust New Zeal J Obstet Gynaecol"},{"key":"10.1016\/j.diabres.2018.04.015_b0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/AOG.0000000000000967","article-title":"Glyburide in women with mild gestational diabetes: a randomized controlled trial","volume":"126","author":"Casey","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.diabres.2018.04.015_b0145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2337\/dc16-2307","article-title":"Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study","volume":"40","author":"Nachum","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12884-017-1505-3","article-title":"Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial","volume":"17","author":"Reynolds","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.diabres.2018.04.015_b0155","doi-asserted-by":"crossref","first-page":"325851","DOI":"10.1155\/2015\/325851","article-title":"Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy","volume":"2015","author":"Ainuddin","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2018.04.015_b0160","first-page":"163","article-title":"A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy","volume":"30","author":"Refuerzo","year":"2015","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.diabres.2018.04.015_b0165","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/humupd\/dmu022","article-title":"First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis","volume":"20","author":"Cassina","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.diabres.2018.04.015_b0170","doi-asserted-by":"crossref","unstructured":"Tieu J, Coat S, Hague W, Middleton P, Shepherd E. Oral anti-diabetic agents for women with established diabetes\/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes. Cochrane Database Syst Rev 2017;10:CD007724.","DOI":"10.1002\/14651858.CD007724.pub3"},{"key":"10.1016\/j.diabres.2018.04.015_b0175","doi-asserted-by":"crossref","first-page":"e0125712","DOI":"10.1371\/journal.pone.0125712","article-title":"Metformin versus insulin in the management of pre-gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial","volume":"10","author":"Beyuo","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2018.04.015_b0180","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00404-013-3090-7","article-title":"The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial","volume":"289","author":"Ibrahim","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.diabres.2018.04.015_b0185","first-page":"1000193","article-title":"Oral hypoglycemic as attractive alternative to insulin for the management of diabetes mellitus during pregnancy","volume":"4","author":"Mohamed","year":"2014","journal-title":"Gynecol Obs"},{"key":"10.1016\/j.diabres.2018.04.015_b0190","doi-asserted-by":"crossref","unstructured":"Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev 2017;11:CD012037.","DOI":"10.1002\/14651858.CD012037.pub2"},{"key":"10.1016\/j.diabres.2018.04.015_b0195","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/dc14-1247","article-title":"Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes","volume":"37","author":"Myngheer","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0200","unstructured":"Metzger BE. HAPO FUS shows persistent ill effects of maternal diabetes. Am. Diabetes Assoc. -\u201377th Sci. Sess. June 9\u201313, 2017, San Diego, Calif., San Diego, California: 2017, p. https:\/\/diabetes.medicinematters.com\/pregnancy\/ges."},{"key":"10.1016\/j.diabres.2018.04.015_b0205","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMoa0902430","article-title":"A multicenter, randomized trial of treatment for mild gestational diabetes","volume":"361","author":"Landon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2018.04.015_b0210","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2337\/dc06-2361","article-title":"Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia","volume":"30","author":"Hillier","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10995-011-0756-2","article-title":"Gestational diabetes and subsequent growth patterns of offspring: the national collaborative perinatal project","volume":"16","author":"Baptiste-Roberts","year":"2012","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.diabres.2018.04.015_b0220","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/AOG.0b013e31828bf70d","article-title":"Risk of childhood obesity in the toddler offspring of mothers with gestational diabetes","volume":"121","author":"Pham","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.diabres.2018.04.015_b0225","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1464-5491.2006.01840.x","article-title":"Glucose tolerance of offspring of mother with gestational diabetes mellitus in a low-risk population","volume":"23","author":"Malcolm","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2018.04.015_b0230","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2337\/dc09-1810","article-title":"Effect of treatment of gestational diabetes mellitus on obesity in the next generation","volume":"33","author":"Gillman","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0235","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2337\/dc14-2159","article-title":"Mild gestational diabetes mellitus and long-term child health","volume":"38","author":"Landon","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0240","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2337\/dc11-0660","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age","volume":"34","author":"Rowan","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0030-1269851","article-title":"Insulin resistance in the control of body fat distribution: a new hypothesis","volume":"43","author":"Ali","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.diabres.2018.04.015_b0250","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2337\/diacare.18.5.611","article-title":"Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism","volume":"18","author":"Silverman","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0255","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc09-2384","article-title":"Maternal glucose at 28 weeks of gestation is not associated with obesity in 2-year-old offspring: the Belfast Hyperglycemia and Adverse Pregnancy Outcome (HAPO) family study","volume":"33","author":"Pettitt","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0260","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-010-1925-3","article-title":"Association of exposure to diabetes in utero with adiposity and fat distribution in a multiethnic population of youth: the Exploring Perinatal Outcomes among Children (EPOCH) Study","volume":"54","author":"Crume","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2018.04.015_b0265","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.2337\/diacare.28.12.2919","article-title":"Anthropometry, glucose tolerance, and insulin concentrations in Indian children: relationships to maternal glucose and insulin concentrations during pregnancy","volume":"28","author":"Krishnaveni","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.ijo.0803163","article-title":"Crossvalidation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children","volume":"30","author":"Brambilla","year":"2006","journal-title":"Int J Obes"},{"key":"10.1016\/j.diabres.2018.04.015_b0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tem.2010.01.009","article-title":"Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity","volume":"21","author":"Unger","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.diabres.2018.04.015_b0280","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1203\/PDR.0b013e318225f9b1","article-title":"The influence of maternal body mass index on infant adiposity and hepatic lipid content","volume":"70","author":"Modi","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.diabres.2018.04.015_b0285","article-title":"Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age; follow-up of two RCTs","author":"Engen Hanem","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2018.04.015_b0290","doi-asserted-by":"crossref","first-page":"e56594","DOI":"10.1371\/journal.pone.0056594","article-title":"Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood","volume":"8","author":"Salom\u00e4ki","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2018.04.015_b0295","doi-asserted-by":"crossref","first-page":"e115778","DOI":"10.1371\/journal.pone.0115778","article-title":"Prenatal metformin exposure in a maternal high fat diet mouse model alters the transcriptome and modifies the metabolic responses of the offspring","volume":"9","author":"Salom\u00e4ki","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2018.04.015_b0300","doi-asserted-by":"crossref","unstructured":"Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and Recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30:S251\u201360.","DOI":"10.2337\/dc07-s225"},{"key":"10.1016\/j.diabres.2018.04.015_b0305","unstructured":"NICE. Diabetes in pregnancy. Management of diabetes and its complications from preconception to the postnatal period; 2015."},{"key":"10.1016\/j.diabres.2018.04.015_b0310","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1210\/jc.2013-2465","article-title":"Diabetes and pregnancy: an endocrine society clinical practice guideline","volume":"98","author":"Blumer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2018.04.015_b0315","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.jcjd.2013.01.044","article-title":"Diabetes and pregnancy","volume":"37","author":"Thompson","year":"2013","journal-title":"Can J Diab"},{"key":"10.1016\/j.diabres.2018.04.015_b0320","doi-asserted-by":"crossref","unstructured":"GEDE. Asistencia a la gestante con diabetes. Gu\u00eda de pr\u00e1ctica cl\u00ednica actualizada en 2014. Av Diabetol 2015;31:45\u201359.","DOI":"10.1016\/j.avdiab.2014.12.001"},{"key":"10.1016\/j.diabres.2018.04.015_b0325","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1097\/AOG.0000000000002159","article-title":"Practice Bulletin No. 180","volume":"130","author":"ACOG-Committee on Practice Bulletins\u2014Obstetrics","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.diabres.2018.04.015_b0330","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.2337\/dc18-S013","article-title":"13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes\u20142018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.04.015_b0335","unstructured":"Society of Maternal-Fetal (SMFM) Publications Committee. Electronic address: pubs@smfm.org. SMFM Statement: Pharmacological treatment of gestational diabetes SMFM Publications Committee. Am J Obstet Gynecol; 2018."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822718305278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822718305278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T05:15:32Z","timestamp":1571202932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822718305278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":67,"alternative-id":["S0168822718305278"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2018.04.015","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy for hyperglycemia in pregnancy \u2013 Do oral agents have a place?","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2018.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}